64 related articles for article (PubMed ID: 38499392)
21. Improved prediction of immune checkpoint blockade efficacy across multiple cancer types.
Chowell D; Yoo SK; Valero C; Pastore A; Krishna C; Lee M; Hoen D; Shi H; Kelly DW; Patel N; Makarov V; Ma X; Vuong L; Sabio EY; Weiss K; Kuo F; Lenz TL; Samstein RM; Riaz N; Adusumilli PS; Balachandran VP; Plitas G; Ari Hakimi A; Abdel-Wahab O; Shoushtari AN; Postow MA; Motzer RJ; Ladanyi M; Zehir A; Berger MF; Gönen M; Morris LGT; Weinhold N; Chan TA
Nat Biotechnol; 2022 Apr; 40(4):499-506. PubMed ID: 34725502
[TBL] [Abstract][Full Text] [Related]
22. CD8
Chen X; Xu R; He D; Zhang Y; Chen H; Zhu Y; Cheng Y; Liu R; Zhu R; Gong L; Xiao M; Wang Z; Deng L; Cao K
Oncogene; 2021 Oct; 40(43):6223-6234. PubMed ID: 34552192
[TBL] [Abstract][Full Text] [Related]
23. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data.
Maeser D; Gruener RF; Huang RS
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34260682
[TBL] [Abstract][Full Text] [Related]
24. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
Fujimoto K; Arita H; Satomi K; Yamasaki K; Matsushita Y; Nakamura T; Miyakita Y; Umehara T; Kobayashi K; Tamura K; Tanaka S; Higuchi F; Okita Y; Kanemura Y; Fukai J; Sakamoto D; Uda T; Machida R; Kuchiba A; Maehara T; Nagane M; Nishikawa R; Suzuki H; Shibuya M; Komori T; Narita Y; Ichimura K
Acta Neuropathol; 2021 Aug; 142(2):323-338. PubMed ID: 34148105
[TBL] [Abstract][Full Text] [Related]
25. Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.
Yokota C; Kagawa N; Takano K; Chiba Y; Kinoshita M; Kijima N; Oji Y; Oka Y; Sugiyama H; Tsuboi A; Izumoto S; Kishima H; Hashimoto N
Cancer Immunol Immunother; 2022 Jan; 71(1):189-201. PubMed ID: 34089373
[TBL] [Abstract][Full Text] [Related]
26. Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2.
Jimenez-García MP; Lucena-Cacace A; Otero-Albiol D; Carnero A
Cell Death Dis; 2021 May; 12(6):515. PubMed ID: 34016958
[TBL] [Abstract][Full Text] [Related]
27.
Gao M; Lin Y; Liu X; Zhao Z; Zhu Z; Zhang H; Ban Y; Bie Y; He X; Sun X; Zhang S
Front Cell Dev Biol; 2021; 9():654407. PubMed ID: 33996815
[TBL] [Abstract][Full Text] [Related]
28.
Olympios N; Gilard V; Marguet F; Clatot F; Di Fiore F; Fontanilles M
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33800183
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis.
Wang W; Wang J; Yang C; Wang J
IUBMB Life; 2021 Jun; 73(6):866-882. PubMed ID: 33759343
[TBL] [Abstract][Full Text] [Related]
30. TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma.
Thomas C; Thierfelder F; Träger M; Soschinski P; Müther M; Edelmann D; Förster A; Geiler C; Kim HY; Filipski K; Harter PN; Schittenhelm J; Eckert F; Ntoulias G; May SA; Stummer W; Onken J; Vajkoczy P; Schüller U; Heppner FL; Capper D; Koch A; Kaul D; Paulus W; Hasselblatt M; Schweizer L
Acta Neuropathol; 2021 Jun; 141(6):959-970. PubMed ID: 33755803
[TBL] [Abstract][Full Text] [Related]
31. Diffuse Glioma Heterogeneity and Its Therapeutic Implications.
Nicholson JG; Fine HA
Cancer Discov; 2021 Mar; 11(3):575-590. PubMed ID: 33558264
[TBL] [Abstract][Full Text] [Related]
32. TERT-Regulation and Roles in Cancer Formation.
Dratwa M; Wysoczańska B; Łacina P; Kubik T; Bogunia-Kubik K
Front Immunol; 2020; 11():589929. PubMed ID: 33329574
[TBL] [Abstract][Full Text] [Related]
33. The cutting-edge progress of immune-checkpoint blockade in lung cancer.
Zhou F; Qiao M; Zhou C
Cell Mol Immunol; 2021 Feb; 18(2):279-293. PubMed ID: 33177696
[TBL] [Abstract][Full Text] [Related]
34. Targeting telomerase for cancer therapy.
Guterres AN; Villanueva J
Oncogene; 2020 Sep; 39(36):5811-5824. PubMed ID: 32733068
[TBL] [Abstract][Full Text] [Related]
35. The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy.
Rudzińska M; Czarnocka B
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370142
[TBL] [Abstract][Full Text] [Related]
36. Tumor antigens in glioma.
Nejo T; Yamamichi A; Almeida ND; Goretsky YE; Okada H
Semin Immunol; 2020 Feb; 47():101385. PubMed ID: 32037183
[TBL] [Abstract][Full Text] [Related]
37. Metabolic landscape of the tumor microenvironment at single cell resolution.
Xiao Z; Dai Z; Locasale JW
Nat Commun; 2019 Aug; 10(1):3763. PubMed ID: 31434891
[TBL] [Abstract][Full Text] [Related]
38. WT1-interacting protein inhibits cell proliferation and tumorigenicity in non-small-cell lung cancer via the AKT/FOXO1 axis.
Wu Z; Qiu M; Mi Z; Meng M; Guo Y; Jiang X; Fang J; Wang H; Zhao J; Liu Z; Qian D; Yuan Z
Mol Oncol; 2019 May; 13(5):1059-1074. PubMed ID: 30690883
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
40. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Jiang P; Gu S; Pan D; Fu J; Sahu A; Hu X; Li Z; Traugh N; Bu X; Li B; Liu J; Freeman GJ; Brown MA; Wucherpfennig KW; Liu XS
Nat Med; 2018 Oct; 24(10):1550-1558. PubMed ID: 30127393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
